Healthpeak Properties (DOC) FY2025 10-K Annual Report

Filed: Feb 3, 2026
Financials
Real Estate Investment TrustsSEC EDGAR

Healthpeak Properties (DOC) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 3, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

Healthpeak Properties FY2025 10-K Analysis

Business Overview

  • Core business model: Own, operate, develop high-quality U.S. healthcare real estate focused on outpatient medical, lab, and senior housing properties
  • New segment emphasis: Preparation for Janus Living IPO, transferring 34 senior housing communities (10,422 units) into a publicly listed REIT structure under majority ownership
+3 more insights

Management Discussion & Analysis

  • Revenue from resident fees and services $568M in 2024, up $41M YoY from $527M
  • Adjusted NOI $159.6M in 2024 vs $135.6M in 2023, +17.7% YoY, driven by higher fees and occupancy despite higher expenses
+4 more insights

Risk Factors

  • U.S. federal policy shifts (NIH funding cuts, drug pricing, tariffs) creating life science tenant funding uncertainty, risking rent payment and expansion
  • Exposure to Medicare/Medicaid funding cuts and Affordable Care Act subsidy expiration impacting tenants in non-expansion states, affecting outpatient medical segment revenues
+3 more insights

Healthpeak Properties FY2025 Key Financial Metrics
XBRL

Revenue

$604M

+6.2% YoY

Net Income

$71M

-70.7% YoY

Net Margin

11.8%

-3096bp YoY

ROE

1.0%

-194bp YoY

Total Assets

$20.3B

+2.0% YoY

EPS (Diluted)

$0.10

-72.2% YoY

Operating Cash Flow

$1.3B

+17.0% YoY

Source: XBRL data from Healthpeak Properties FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Healthpeak Properties

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.